LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery

Photo from wikipedia

SOURCE CITATION McCarthy MW, Naggie S, Boulware DR, et al. Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical… Click to show full abstract

SOURCE CITATION McCarthy MW, Naggie S, Boulware DR, et al. Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial. JAMA. 2023;329:296-305. 36633838.

Keywords: mild moderate; time sustained; moderate covid; outpatients mild; fluvoxamine; sustained recovery

Journal Title: Annals of Internal Medicine
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.